2025-01-01 2025-12-31 2025-12-31 false 13056696 Sutri Nutrition And Wellbeing Ltd 86900 Other human health activities iso4217:GBP xbrli:pure 13056696 2025-01-01 13056696 2025-12-31 13056696 2025-01-01 2025-12-31 13056696 bus:SmallEntities 2025-01-01 2025-12-31 13056696 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 13056696 bus:FullAccounts 2025-01-01 2025-12-31 13056696 core:WithinOneYear 2025-12-31 13056696 core:AfterOneYear 2025-12-31 13056696 core:WithinOneYear 2025-01-01 2025-12-31 13056696 core:AfterOneYear 2025-01-01 2025-12-31 13056696 core:CurrentFinancialInstruments 2025-12-31 13056696 core:Non-currentFinancialInstruments 2025-12-31 13056696 core:CurrentFinancialInstruments 2025-01-01 2025-12-31 13056696 core:Non-currentFinancialInstruments 2025-01-01 2025-12-31 13056696 core:LandBuildings 2025-01-01 2025-12-31 13056696 core:FurnitureFittings 2025-01-01 2025-12-31 13056696 core:OfficeEquipment 2025-01-01 2025-12-31 13056696 core:Vehicles 2025-01-01 2025-12-31 13056696 core:PlantMachinery 2025-01-01 2025-12-31 13056696 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 13056696 core:LandBuildings 2025-12-31 13056696 core:PlantMachinery 2025-12-31 13056696 core:Vehicles 2025-12-31 13056696 core:FurnitureFittings 2025-12-31 13056696 core:OfficeEquipment 2025-12-31 13056696 core:OtherPropertyPlantEquipment 2025-12-31 13056696 core:Right-of-useAssets 2025-01-01 2025-12-31 13056696 core:Right-of-useAssets 2025-12-31 13056696 core:Goodwill 2025-01-01 2025-12-31 13056696 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 13056696 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 13056696 core:OtherResidualIntangibleAssets 2025-01-01 2025-12-31 13056696 core:Goodwill 2025-12-31 13056696 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 13056696 core:PatentsTrademarksLicencesConcessionsSimilar 2025-12-31 13056696 core:OtherResidualIntangibleAssets 2025-12-31 13056696 dpl:CostSales 2025-01-01 2025-12-31 13056696 dpl:AdministrativeExpenses 2025-01-01 2025-12-31 13056696 dpl:DistributionCosts 2025-01-01 2025-12-31 13056696 core:ShareCapital 2025-12-31 13056696 core:SharePremium 2025-12-31 13056696 core:RevaluationReserve 2025-12-31 13056696 core:OtherReservesSubtotal 2025-12-31 13056696 core:ShareCapitalPreferenceShares 2025-12-31 13056696 core:CapitalRedemptionReserve 2025-12-31 13056696 core:OtherCapitalReserve 2025-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2025-12-31 13056696 core:ShareCapital 2025-01-01 2025-12-31 13056696 core:SharePremium 2025-01-01 2025-12-31 13056696 core:RevaluationReserve 2025-01-01 2025-12-31 13056696 core:OtherReservesSubtotal 2025-01-01 2025-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 13056696 1 2025-01-01 2025-12-31 13056696 2 2025-01-01 2025-12-31 13056696 core:ShareCapital 1 2025-01-01 2025-12-31 13056696 core:ShareCapital 2 2025-01-01 2025-12-31 13056696 core:SharePremium 1 2025-01-01 2025-12-31 13056696 core:SharePremium 2 2025-01-01 2025-12-31 13056696 core:RevaluationReserve 1 2025-01-01 2025-12-31 13056696 core:RevaluationReserve 2 2025-01-01 2025-12-31 13056696 core:RetainedEarningsAccumulatedLosses 1 2025-01-01 2025-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2 2025-01-01 2025-12-31 13056696 1 2025-01-01 2025-12-31 13056696 core:Non-currentFinancialInstruments core:CostValuation 2025-01-01 13056696 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:CostValuation 2025-12-31 13056696 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2025-01-01 13056696 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal 2025-12-31 13056696 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2025-12-31 13056696 core:Non-currentFinancialInstruments 2025-12-31 13056696 core:Non-currentFinancialInstruments 2024-12-31 13056696 2024-01-01 13056696 2024-12-31 13056696 2024-01-01 2024-12-31 13056696 core:WithinOneYear 2024-12-31 13056696 core:AfterOneYear 2024-12-31 13056696 core:CurrentFinancialInstruments 2024-12-31 13056696 core:Non-currentFinancialInstruments 2024-12-31 13056696 core:LandBuildings 2024-12-31 13056696 core:PlantMachinery 2024-12-31 13056696 core:Vehicles 2024-12-31 13056696 core:FurnitureFittings 2024-12-31 13056696 core:OfficeEquipment 2024-12-31 13056696 core:OtherPropertyPlantEquipment 2024-12-31 13056696 core:Right-of-useAssets 2024-12-31 13056696 core:Goodwill 2024-12-31 13056696 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 13056696 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 13056696 core:OtherResidualIntangibleAssets 2024-12-31 13056696 dpl:AdministrativeExpenses 2024-01-01 2024-12-31 13056696 core:ShareCapital 2024-12-31 13056696 core:SharePremium 2024-12-31 13056696 core:RevaluationReserve 2024-12-31 13056696 core:OtherReservesSubtotal 2024-12-31 13056696 core:ShareCapitalPreferenceShares 2024-12-31 13056696 core:CapitalRedemptionReserve 2024-12-31 13056696 core:OtherCapitalReserve 2024-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2024-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2024-01-01 13056696 core:ShareCapital 2024-01-01 13056696 core:SharePremium 2024-01-01 13056696 core:RevaluationReserve 2024-01-01 13056696 core:ShareCapital 2024-01-01 2024-12-31 13056696 core:SharePremium 2024-01-01 2024-12-31 13056696 core:RevaluationReserve 2024-01-01 2024-12-31 13056696 core:OtherReservesSubtotal 2024-01-01 2024-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 13056696 1 2024-01-01 2024-12-31 13056696 2 2024-01-01 2024-12-31 13056696 core:ShareCapital 1 2024-01-01 2024-12-31 13056696 core:ShareCapital 2 2024-01-01 2024-12-31 13056696 core:SharePremium 1 2024-01-01 2024-12-31 13056696 core:SharePremium 2 2024-01-01 2024-12-31 13056696 core:RevaluationReserve 1 2024-01-01 2024-12-31 13056696 core:RevaluationReserve 2 2024-01-01 2024-12-31 13056696 core:RetainedEarningsAccumulatedLosses 1 2024-01-01 2024-12-31 13056696 core:RetainedEarningsAccumulatedLosses 2 2024-01-01 2024-12-31 13056696 bus:Director1 2025-01-01 2025-12-31 13056696 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31
Sutri Nutrition And Wellbeing Ltd
Unaudited Financial Statements
for the year ended 31 December 2025
Company registration number 13056696
(England and Wales)

# Company Information

For the year ended 31 December 2025

Director | Lartey, Belinda Jennifer Naa Tsitseh

Registered office | 172 Church Road
| Croydon
| CR0 1SE

Registered number | 13056696

Accountant | Luemas Consult Ltd

# Statement of Financial Position

As at 31 December 2025

2025
2024
£
£
£
£
Current assets
Debtors
573
677
573
677
Creditors
Amounts falling due within one year
(300)
-
(300)
-
Net current assets (liabilities)
273
677
Total assets less current liabilities
273
677
Creditors
Amounts falling due after one year
(2,395)
(2,396)
(2,395)
(2,396)
Net assets (liabilities)
(2,122)
(1,719)
Capital and reserves
Called up share capital
1
-
Profit and loss account
(2,123)
(1,719)
Total equity
(2,122)
(1,719)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 2 July 2026 and are signed on its behalf by:

Lartey, Belinda Jennifer Naa Tsitseh Lartey, Belinda Jennifer Naa Tsitseh Director |

Company registration number 13056696

# Notes to the Financial Statements

For the year ended 31 December 2025

### 1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

### 2. Accounting policies

### 2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

### 3. Employees

The average number of employees during the year was 1 (2024: 1).